Parkinson's Disease. Parkinson's disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of Parkinson’s disease confirmed by a qualified neurologist specializing in movement disorders, based on the UK PD Society Brain Bank criteria. Willingness to participate in the study No cognitive impairment, as determined in consultation with a neurologist specializing in movement disorders Ability to read and write Native Persian speaker Participation of a family member in the sessions alongside the patient, preferably the primary caregiver
Exclusion criteria
Exclusion criteria: Use of psychiatric medications Concurrent participation in educational sessions or other therapeutic-care interventions related to Parkinson’s disease during the study period. Physical illness that would prevent participation in the study History of acute or chronic psychiatric disorders History of acute or chronic neurological conditions such as stroke or traumatic brain injury Hearing or vision impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before, after, 1 month after. Method of measurement: Parkinson Disease Quality of life(PDQ-8).;Fatigue. Timepoint: Before, after, 1 month after. Method of measurement: Parkinson Fatigue Scale(PFS-16).;Self Efficacy. Timepoint: Before, after, 1 month after. Method of measurement: General Self Efficacy(GSE-17). | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences